Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 146 clinical trials
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer …

motivational interviewing
nicotine replacement
lung cancer screening
nicotine lozenge
John Muir Health
 (2.2 away) Contact site
  • 05 Nov, 2020
  • +17 other locations
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy Surgery and/or Radiation Therapy

This randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human epidermal growth factor receptor 2 (HER2) negative breast cancer after chemotherapy, surgery, and/or radiation therapy. Aspirin is a drug that reduces pain, fever, inflammation, and blood clotting. It …

Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 20 Nov, 2020
  • +1534 other locations
Baroreflex Activation Therapy for Heart Failure

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System in subjects with heart failure, defined as New York Heart Association (NYHA) functional Class III, left ventricular ejection fraction (LVEF) 35% and NT-proBNP<1600 pg/ml …

cardiac resynchronization therapy
medical therapy
ejection fraction
John Muir Health Clinical Research Center
 (5.2 away) Contact site
  • 22 Dec, 2019
  • +121 other locations
GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants

The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 months of age, when administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines(RIV).

conjugate vaccine
GSK Investigational Site
 (0.7 away) Contact site
  • 23 Sep, 2020
  • +42 other locations
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Safety and efficacy of nemolizumab in subjects with moderate-to-severe atopic dermatitis

Galderma Investigational Site
 (2.2 away) Contact site
  • 27 Nov, 2020
  • +214 other locations
Open-label Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of LOU064 in Subjects With CSU

This study is an open-label, single arm, multicenter, long-term safety and tolerability extension study for CSU patients who completed CLOU064A2201 or other preceding studies with LOU064

Novartis Investigative Site
 (4.7 away) Contact site
  • 26 Oct, 2020
  • +52 other locations
Contra Costa Health Services Whole Person Care (CommunityConnect) Program Evaluation

Contra Costa Health System's WPC Pilot Program, titled Community Connect (CMCT), delivers case management and linkage services to high-risk Medi-Cal members in Contra Costa County, California. This program is funded under the CMS/DHCS 1115 Waiver Whole Person Care (WPC) Pilot Program through 2020. High-risk individuals from the population of Contra …

Contra Costa Whole Person Care Program
 (5.2 away) Contact site
  • 01 Jul, 2019
  • 1 location
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.

serologic test
abdominal pain
Innovate Research Site
 (2.2 away) Contact site
  • 29 Nov, 2020
  • +189 other locations
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors Including Central Nervous System Tumors

Phase 1 of this study, utilizing a rolling 6 design, will be conducted to determine a maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), and to describe the toxicities of lenvatinib administered in combination with everolimus once daily to pediatric participants with recurrent/refractory solid tumors. Phase 2, utilizing …

Kaiser Permenente
 (9.2 away) Contact site
  • 25 Jun, 2020
  • +54 other locations
Multiple Dose Study to Evaluate the Efficacy Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

This is a randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety, and pharmacodynamics (PD) of multiple doses of REMD-477 in subjects who have Type 1 diabetes and are currently receiving insulin treatment. This study will determine whether REMD-477 can decrease daily insulin requirements and improve glycemic control after 12 …

Diablo Clinical Research
 (2.2 away) Contact site
  • 21 Oct, 2020
  • +10 other locations